Town Hall: H.R.3 Creates A False Choice Between Drug Supply and Price

In exchange for some short-term price reduction, H.R.3 threatens access to medicine, innovation, research, and drug shortages, which can negatively impact the U.S. healthcare system. Reforming Pharmacy Benefit Managers, for example, rather than establishing price controls or allowing medications to be imported from Canada, is essential for lowering drug prices in a system that currently lacks transparency.

This article is available in its entirety in Town Hall.

FacebooktwitterredditlinkedinFacebooktwitterredditlinkedin